Whalesbook
Vijaya Diagnostic Centre Ltd is bolstering its board with the appointment of two new Independent Directors, Mr. Ravi Shankararamiah and Dr. Sasikala Paruchuri Kola. The appointments received overwhelming approval from shareholders through a postal ballot and remote e-voting process.
Shareholders cast their votes between April 10 and May 09, 2026. Mr. Ravi Shankararamiah secured 99.9994% of the votes in favour, while Dr. Sasikala Paruchuri Kola received 99.9995% approval. The company confirmed the outcomes based on the Scrutinizer's report.
These appointments are significant for corporate governance. Independent directors provide an objective viewpoint, help protect minority shareholder interests, and ensure ethical business conduct. The addition of Mr. Shankararamiah and Dr. Kola is expected to bring valuable experience and enhance oversight, reinforcing Vijaya Diagnostics' commitment to strong governance standards.
The company, a leading provider of diagnostic services with a wide network of lab and radiology centres, has a history of focusing on board quality. In May 2023, Vijaya Diagnostics appointed Mr. Murali Krishna Nalluri as a Non-Executive Independent Director, signalling a continuous effort to strengthen its governance framework.
With these new appointments, the board gains enhanced expertise and oversight capabilities. This move underscores the company's dedication to independent decision-making and good corporate governance, with shareholders showing strong confidence in the nominated directors.
While the filing did not detail specific risks associated with these appointments, investors will be watching for the new directors' contributions to future strategy and governance.
Other major diagnostic players in India, such as Dr. Lal PathLabs and Metropolis Healthcare, also prioritize independent board representation as a key aspect of their governance practices, alongside network expansion and service offerings.
The voting involved 402 members for Mr. Ravi Shankararamiah's appointment and 403 members for Dr. Sasikala Paruchuri Kola's. On the record date of April 03, 2026, the company had 63,545 shareholders.